Mr. Fried is a partner in FBC's Corporate Department.
Mr. Fried has a diverse corporate practice encompassing a broad range of corporate and commercial matters that include private equity and venture capital transactions, mergers & acquisitions, and the legal aspects of the operations of high-tech and life sciences companies, including the licensing and sale of technology.
Mr. Fried advises hi-tech companies from their early stages, and provides consultation regarding all legal, business and commercial aspects of their activities.
Mr. Fried has represented public and private acquirers, target companies, and private equity firms in a variety of domestic and cross-border mergers & acquisitions, joint ventures, restructurings, and other corporate matters. He also advised venture capital funds and companies regarding a wide array of finance and investment agreements.
Bar-Ilan University, LL.B., 2008
La Dolce Vita Way of Life Congratulations to our client Sky Fund for the acquisition of 50% of the shares of Dolce Vita Way of Life Ltd. at a company value of approximately NIS 220 million, according to media reports. This is the first acquisition by Sky 4 Private Equi...Raz Tepper & Shmulik Fried & Ziv Schwartz & Omri Rachum-Twaig, Dr. & Ben Strauss & Hilla Sachs | Mar 2022
Representation of XT Investments Ltd. as a selling shareholder in the NIS 281M initial public offering in Israel and international offering of Terminal X Online Limited. Terminal X is Israel’s leading online fashion retailer. The initial public offering of Terminal X...Sharon Rosen & Vered Oren & Shmulik Fried & Anat Shavit | Oct 2021
The Israel Innovation Authority published a "Call for Proposals" pursuant to which manufacturing companies are invited to submit applications for support in R&D plans or "pilots" offering technological innovation with respect to products and solutions for the preven...Raz Tepper & Shmulik Fried | Mar 2020
רשות החדשנות בשיתוף עם משרד הכלכלה והתאחדות התעשיינים בישראל פרסמו "קול קורא" במסגרתו מוזמנות חברות תעשייתיות להגיש בקשות לקבלת סיוע לתוכניות מו"פ או תוכניות הרצה ("פיילוטים"), המהוות חדשנות טכנולוגית לפתרונות שנועדו למניעה, טיפול והתמודדות עם נגיף הקורונה, וזאת עד ליום...Raz Tepper & Shmulik Fried | Mar 2020
Representation of the general partner in the incorporation of Surround Ventures, a new venture capital fund, which will be focused in making investments in early stage companies in the field of media and entertainment. The fund, backed by Randi Zuckerberg, founder of...Raz Tepper & Shmulik Fried | Dec 2019
FBC acted as an Israeli counsel for Greenbriar Equity Group L.P. in its acquisition of all of the outstanding shares of Arotech Corp. (NASDAQ: ARTX) for an aggregate equity value of approximately US$80.8 million. The transaction is expected to close in the first quar...Raz Tepper & Anat Shavit & Sharon Madel-Artzy & Shmulik Fried & Moran Friedman | Sep 2019
FBC represented OrbiMed in its $5,325,000 investment in MobileODT Ltd. as part of a Series B Round of approximately $6,825,000 investment, in addition to conversion of SAFEs ("simple agreement for future equity") in the amount of $3,905,223. The transaction included ...Raz Tepper & Shmulik Fried | Jul 2017
Click here to view the full update New Rules Published by the Israeli Innovation Authority In May 2017, the Israeli Innovation Authority (the successor of the Office of Chief Scientist), a division of the Israeli Ministry of Economy and Industry (the "Innovation A...Raz Tepper & Shmulik Fried | Jun 2017
FBC represented QUALCOMM Ventures, in leading a $5 Million investment in Prospera Technologies Ltd., as part of a Series B round of $15 Million. The other investors included Bessemer Venture Partners, Cisco Investments BV and others. QUALCOMM, traded on Nasdaq, is a gl...Raz Tepper & Shmulik Fried | Mar 2017
FBC acted as Israeli counsel to Octopus Ventures, who was the lead investor in the financing round of $14.5 million of MediaSafe Project Ltd., an Israeli company whose primarily business is in the healthcare IT field. For press, click hereRaz Tepper & Shmulik Fried | Feb 2017